Patent 9139516 was granted and assigned to Catabasis Pharmaceuticals on September, 2015 by the United States Patent and Trademark Office.
The invention relates to Fatty Acid Acetylated Salicylate Derivatives; compositions comprising an effective amount of a Fatty Acid Acetylated Salicylate Derivative; and methods for treating or preventing an inflammatory disorder comprising the administration of an effective amount of a Fatty Acid Acetylated Salicylate Derivative.